| 1 |
35421557 | The combined anti-osteoporotic effects of simvastatin and exercise in ovariectomized mice fed a high-fat diet. | 2022 Jul |
2 |
| 2 |
28463564 | Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic Factors. | 2017 Jul 3 |
1 |
| 3 |
26713363 | Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cells. | 2016 Jan 22 |
1 |
| 4 |
24039733 | Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss. | 2013 |
5 |
| 5 |
21832867 | Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species. | 2011 Nov 30 |
2 |
| 6 |
20346376 | Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. | 2010 Jun 8 |
4 |
| 7 |
16278780 | Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures. | 2005 Oct |
1 |